Marine biome-derived secondary metabolites, a class of promising antineoplastic agents : A systematic review on their classification, mechanism of action and future perspectives
Copyright © 2022 Elsevier B.V. All rights reserved..
Cancer is one of the most deadly diseases on the planet. Over the past decades, numerous antineoplastic compounds have been discovered from natural resources such as medicinal plants and marine species as part of multiple drug discovery initiatives. Notably, several marine flora (e.g. Ascophyllum nodosum, Sargassum thunbergii) have been identified as a rich source for novel cytotoxic compounds of different chemical forms. Despite the availability of enormous chemically enhanced new resources, the anticancer potential of marine flora and fauna has received little attention. Interestingly, numerous marine-derived secondary metabolites (e.g., Cytarabine, Trabectedin) have exhibited anticancer effects in preclinical cancer models. Most of the anticancer drugs obtained from marine sources stimulated apoptotic signal transduction pathways in cancer cells, such as the intrinsic and extrinsic pathways. This review highlights the sources of different cytotoxic secondary metabolites obtained from marine bacteria, algae, fungi, invertebrates, and vertebrates. Furthermore, this review provides a comprehensive overview of the utilisation of numerous marine-derived cytotoxic compounds as anticancer drugs, as well as their modes of action (e.g., molecular target). Finally, it also discusses the future prospects of marine-derived drug developments and their constraints.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:836 |
|---|---|
| Enthalten in: |
The Science of the total environment - 836(2022) vom: 25. Aug., Seite 155445 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sugumaran, Abimanyu [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anticancer agents |
|---|
| Anmerkungen: |
Date Completed 08.06.2022 Date Revised 08.06.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.scitotenv.2022.155445 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM340195851 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM340195851 | ||
| 003 | DE-627 | ||
| 005 | 20231226004608.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.scitotenv.2022.155445 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1133.xml |
| 035 | |a (DE-627)NLM340195851 | ||
| 035 | |a (NLM)35490806 | ||
| 035 | |a (PII)S0048-9697(22)02539-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sugumaran, Abimanyu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Marine biome-derived secondary metabolites, a class of promising antineoplastic agents |b A systematic review on their classification, mechanism of action and future perspectives |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.06.2022 | ||
| 500 | |a Date Revised 08.06.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Elsevier B.V. All rights reserved. | ||
| 520 | |a Cancer is one of the most deadly diseases on the planet. Over the past decades, numerous antineoplastic compounds have been discovered from natural resources such as medicinal plants and marine species as part of multiple drug discovery initiatives. Notably, several marine flora (e.g. Ascophyllum nodosum, Sargassum thunbergii) have been identified as a rich source for novel cytotoxic compounds of different chemical forms. Despite the availability of enormous chemically enhanced new resources, the anticancer potential of marine flora and fauna has received little attention. Interestingly, numerous marine-derived secondary metabolites (e.g., Cytarabine, Trabectedin) have exhibited anticancer effects in preclinical cancer models. Most of the anticancer drugs obtained from marine sources stimulated apoptotic signal transduction pathways in cancer cells, such as the intrinsic and extrinsic pathways. This review highlights the sources of different cytotoxic secondary metabolites obtained from marine bacteria, algae, fungi, invertebrates, and vertebrates. Furthermore, this review provides a comprehensive overview of the utilisation of numerous marine-derived cytotoxic compounds as anticancer drugs, as well as their modes of action (e.g., molecular target). Finally, it also discusses the future prospects of marine-derived drug developments and their constraints | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a Anticancer agents | |
| 650 | 4 | |a Apoptosis | |
| 650 | 4 | |a Drug discovery | |
| 650 | 4 | |a Marine microorganisms | |
| 650 | 4 | |a Marine-derived products | |
| 650 | 4 | |a Secondary metabolites | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 650 | 7 | |a Biological Products |2 NLM | |
| 700 | 1 | |a Pandiyan, Rajesh |e verfasserin |4 aut | |
| 700 | 1 | |a Kandasamy, Palanivel |e verfasserin |4 aut | |
| 700 | 1 | |a Antoniraj, Mariya Gover |e verfasserin |4 aut | |
| 700 | 1 | |a Navabshan, Irfan |e verfasserin |4 aut | |
| 700 | 1 | |a Sakthivel, Balasubramaniyan |e verfasserin |4 aut | |
| 700 | 1 | |a Dharmaraj, Selvakumar |e verfasserin |4 aut | |
| 700 | 1 | |a Chinnaiyan, Santhosh Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Ashokkumar, Veeramuthu |e verfasserin |4 aut | |
| 700 | 1 | |a Ngamcharussrivichai, Chawalit |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Science of the total environment |d 1972 |g 836(2022) vom: 25. Aug., Seite 155445 |w (DE-627)NLM000215562 |x 1879-1026 |7 nnns |
| 773 | 1 | 8 | |g volume:836 |g year:2022 |g day:25 |g month:08 |g pages:155445 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.scitotenv.2022.155445 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 836 |j 2022 |b 25 |c 08 |h 155445 | ||